Online Education: Research Roundtable

Join us as we delve into all of the exciting clinical research projects underway in HHT! Cassi Friday, PhD (Overview) will provide an overview of what goes into a clinical trial. Dr. Marie Faughnan (Brain AVM Study), Dr. Keith McCrae (PATH Study), Dr. James Gossage (Pazopanib Trial), and Brian Mangilog (Rare Genomes Project) will share more research projects and the potential impacts for patients…

Learn More >>

Cure HHT Welcomes Cassi Friday, PhD

Cure HHT is thrilled to welcome Cassi Friday, PhD as the newest member of our team! Get to know Cassi, her connection to HHT, and learn more about her role as Director of Cure HHT Research Programs & Grants.

Learn More >>

Patient & Physician Conferences Announced!

Join members of our HHT community – patients and physicians alike – as we come together for our both regional and national conferences to meet members of our local and extended HHT community, as well as learn more about HHT and share new scientific advancements. This year, medical professionals can now receive CME credits for participation!

Open registration dates will be released soon.

Learn More >>
Research RoundTable_web

Online Education: Research Roundtable

Welcome Cassi Friday, PhD

Cure HHT Welcomes Cassi Friday, PhD

HHT Academy Logo

Patient & Physician Conferences Announced!

2022 Year in Review - Cure HHT

Thank You for an Amazing Year

Social Share_OTCE_web

Help Keep Us On the Cutting Edge

Text to Give

NEW! Text to Give

New Therapeutic Development Arm

New Therapeutic Development Arm Takes Shape

Lynn - March of Dimes 3

Lynne Sekarski, RN receives the Heroes in Action Award from the March of Dimes

Find Support

Connect with the Cure HHT community and find the latest resources including treatment centers, patient conferences, webinars and more.

Research for a Cure

Thanks to our supporters we're making exciting strides - gaining new insights into the cause, development and progression of this disease.

Who We Are

Constantly working for a brighter future for those with HHT through awareness, education and research - Cure HHT is the cornerstone of the HHT Community.

International HHT Guidelines

EXPLORE RECOMMENDATIONS BY TOPIC AREA, VIEW CUSTOM CARE CHECKLISTS, AND MUCH MORE.

Find the most up-to-date resources to manage your HHT.

Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu Syndrome, is an inherited disease that leads to malformed blood vessels in multiple organs of the body and typically begins with nosebleeds during childhood. HHT can result in serious health problems if not promptly diagnosed and treated. Our mission is to find a cure for HHT while saving the lives and improving the well-being of individuals and families affected by HHT.

1 in
Hereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder of the blood vessels that affects approximately 1 in 5,000 people worldwide.
%
of people with HHT are undiagnosed